The involvement of cytochrome p450 (CYP) 26 in the retinoic acid metabolism of human epidermal keratinocytes

Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids

Volumn 1791, Issue 3, 2009, Pages 220-228

  Pavez Loriè, Elizabeth ^a   Li, Hao ^a   Vahlquist, Anders ^a   Törmä, Hans ^a  

^a UPPSALA UNIVERSITY   (Sweden)

Author keywords

All trans retinoic acid; Cytochrome P450; Epidermis; Keratinocytes; Metabolism; Retinol

Indexed keywords

BIOLOGICAL MARKER; CALCIUM CHLORIDE; CELLULAR RETINOIC ACID BINDING PROTEIN II; COMPLEMENTARY DNA; CYTOCHROME P450 26A1; CYTOCHROME P450 26B1; ENZYME INHIBITOR; KETOCONAZOLE; LIAROZOLE; MESSENGER RNA; N [4 [2 ETHYL 1 (1H 1,2,4 TRIAZOL 1 YL)BUTYL]PHENYL] 2 BENZOTHIAZOLAMINE; RETINOIC ACID; RETINOIC ACID BINDING PROTEIN; RETINOID; RETINOL; SMALL INTERFERING RNA; TALAROZOLE; TRITIUM; UNCLASSIFIED DRUG;

ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; ENZYME ACTIVITY; EPIDERMIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; KERATINOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; VITAMIN METABOLISM;

BENZOTHIAZOLES; CALCIUM; CELL DIFFERENTIATION; CELLS, CULTURED; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CYTOCHROME P-450 ENZYME SYSTEM; EPIDERMIS; FLUORESCENT ANTIBODY TECHNIQUE; FORESKIN; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; IMMUNOBLOTTING; INFANT, NEWBORN; KERATINOCYTES; MALE; RECEPTORS, RETINOIC ACID; RNA, MESSENGER; RNA, SMALL INTERFERING; TRETINOIN; TRIAZOLES; VITAMIN A;

EID: 60549107461     PISSN: 13881981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbalip.2008.12.004     Document Type: Article

References (49)

1. Vahlquist A. Role of retinoids in normal and diseased skin. In: Blomhoff R. (Ed). Vitamin A in Health and Disease (1994), M. Dekker, New York 365-424
2. Peck G.L., and DiGiovanna J.J. Synthetic retinoids in dermatology. In: Sporn M.B., Roberts A.B., and Goodman D.S. (Eds). The Retinoids : Biology, Chemistry, and Medicine (1994), Raven Press, New York 631-658
3. Orfanos C.E., Zouboulis C.C., Almond-Roesler B., and Geilen C.C. Current use and future potential role of retinoids in dermatology. Drugs 53 (1997) 358-388
4. Sorg O., Kuenzli S., and Saurat J.H. Side effects and pitfalls in retinoid therapy. In: Vahlquist A., and Duvic M. (Eds). Retinoids and Carotenoids in Dermatology (2007), Informa Healthcare USA Inc., New York 225-248
5. Fuchs E., and Green H. Regulation of terminal differentiation of cultured human keratinocytes by vitamin A. Cell 25 (1981) 617-625
6. Asselineau D., Bernard B.A., Bailly C., and Darmon M. Retinoic acid improves epidermal morphogenesis. Dev. Biol. 133 (1989) 322-335
7. Ghyselinck N., and Chambon P. Animal models for retinoid receptor research; implications for epidermal homeostasis, skin barrier function, wound healing and atopic dermatitis. In: Vahlquist A., and Duvic M. (Eds). Retinoids and Carotenoids in Dermatology (2007), Informa Healthcare USA Inc., New York 27-54
8. Kurlandsky S.B., Duell E.A., Kang S., Voorhees J.J., and Fisher G.J. Auto-regulation of retinoic acid biosynthesis through regulation of retinol esterification in human keratinocytes. J. Biol. Chem. 271 (1996) 15346-15352
9. Blomhoff R., and Blomhoff H. From carotenoids and vitamin A to retinoids. In: Vahlquist A., and Duvic M. (Eds). Retinoids and Carotenoids in Dermatology (2007), Informa Healthcare USA Inc., New York 1-26
10. White J.A., Guo Y.D., Baetz K., Beckett-Jones B., Bonasoro J., Hsu K.E., Dilworth F.J., Jones G., and Petkovich M. Identification of the retinoic acid-inducible all-trans-retinoic acid 4-hydroxylase. J. Biol. Chem. 271 (1996) 29922-29927
11. White J.A., Beckett-Jones B., Guo Y.D., Dilworth F.J., Bonasoro J., Jones G., and Petkovich M. cDNA cloning of human retinoic acid-metabolizing enzyme (hP450RAI) identifies a novel family of cytochromes P450. J. Biol. Chem. 272 (1997) 18538-18541
12. Taimi M., Helvig C., Wisniewski J., Ramshaw H., White J., Amad M., Korczak B., and Petkovich M. A novel human cytochrome P450, CYP26C1, involved in metabolism of 9-cis and all-trans isomers of retinoic acid. J. Biol. Chem. 279 (2004) 77-85
13. Abu-Abed S.S., Beckett B.R., Chiba H., Chithalen J.V., Jones G., Metzger D., Chambon P., and Petkovich M. Mouse P450RAI (CYP26) expression and retinoic acid-inducible retinoic acid metabolism in F9 cells are regulated by retinoic acid receptor gamma and retinoid X receptor alpha. J. Biol. Chem. 273 (1998) 2409-2415
14. Loudig O., Babichuk C., White J., Abu-Abed S., Mueller C., and Petkovich M. Cytochrome P450RAI(CYP26) promoter: a distinct composite retinoic acid response element underlies the complex regulation of retinoic acid metabolism. Mol. Endocrinol. 14 (2000) 1483-1497
15. Randolph R.K., and Simon M. Metabolism of all-trans-retinoic acid by cultured human epidermal keratinocytes. J. Lipid Res. 38 (1997) 1374-1383
16. Ray W.J., Bain G., Yao M., and Gottlieb D.I. CYP26, a novel mammalian cytochrome P450, is induced by retinoic acid and defines a new family. J. Biol. Chem. 272 (1997) 18702-18708
17. Loudig O., Maclean G.A., Dore N.L., Luu L., and Petkovich M. Transcriptional co-operativity between distant retinoic acid response elements in regulation of Cyp26A1 inducibility. Biochem. J. 392 (2005) 241-248
18. Smith G., Wolf C.R., Deeni Y.Y., Dawe R.S., Evans A.T., Comrie M.M., Ferguson J., and Ibbotson S.H. Cutaneous expression of cytochrome P450 CYP2S1: individuality in regulation by therapeutic agents for psoriasis and other skin diseases. Lancet 361 (2003) 1336-1343
19. Heise R., Mey J., Neis M.M., Marquardt Y., Joussen S., Ott H., Wiederholt T., Kurschat P., Megahed M., Bickers D.R., Merk H.F., and Baron J.M. Skin retinoid concentrations are modulated by CYP26AI expression restricted to basal keratinocytes in normal human skin and differentiated 3D skin models. J. Invest. Dermatol. (2006)
20. Popa C., Dicker A.J., Dahler A.L., and Saunders N.A. Cytochrome P450, CYP26AI, is expressed at low levels in human epidermal keratinocytes and is not retinoic acid-inducible. Br. J. Dermatol. 141 (1999) 460-468
21. Kang S., Duell E.A., Kim K.J., and Voorhees J.J. Liarozole inhibits human epidermal retinoic acid 4-hydroxylase activity and differentially augments human skin responses to retinoic acid and retinol in vivo. J. Invest. Dermatol. 107 (1996) 183-187
22. Stoppie P., Borgers M., Borghgraef P., Dillen L., Goossens J., Sanz G., Szel H., Van Hove C., Van Nyen G., Nobels G., Vanden Bossche H., Venet M., Willemsens G., and Van Wauwe J. R115866 inhibits all-trans-retinoic acid metabolism and exerts retinoidal effects in rodents. J. Pharmacol. Exp. Ther. 293 (2000) 304-312
23. Van Wauwe J., Van Nyen G., Coene M.C., Stoppie P., Cools W., Goossens J., Borghgraef P., and Janssen P.A. Liarozole, an inhibitor of retinoic acid metabolism, exerts retinoid-mimetic effects in vivo. J. Pharmacol. Exp. Ther. 261 (1992) 773-779
24. van Wauwe J., Coene M.-C., Goossens J., Cools W., and Monbaliu J. Effects of cytochrome p-450 inhibitors on the in vivo metabolism of all-trans-retinoic acid. J. Pharmacol. Exp. Ther. 252 (1990) 365-369
25. Van Wauwe J.P., Coene M.C., Goossens J., Van Nijen G., Cools W., and Lauwers W. Ketoconazole inhibits the in vitro and in vivo metabolism of all-trans-retinoic acid. J. Pharmacol. Exp. Ther. 245 (1988) 718-722
26. Dockx P., Decree J., and Degreef H. Inhibition of the metabolism of endogenous retinoic acid as treatment for severe psoriasis: an open study with oral liarozole. Br. J. Dermatol. 133 (1995) 426-432
27. Lucker G.P., Heremans A.M., Boegheim P.J., van de Kerkhof P.C., and Steijlen P.M. Oral treatment of ichthyosis by the cytochrome P-450 inhibitor liarozole. Br. J. Dermatol. 136 (1997) 71-75
28. Lucker G.P., Verfaille C.J., Heremans A.M., Vanhoutte F.P., Boegheim J.P., and Steijlen P.P. Topical liarozole in ichthyosis: a double-blind, left-right comparative study followed by a long-term open maintenance study. Br. J. Dermatol. 152 (2005) 566-569
29. E. Pavez Loriè, A. Gånemo, M. Borgers, L. Wouters, S. Blockhuys, L. vandePlassche, H. Törmä, A. Vahlquist, The epidermal expression of retinoid-regulated genes is similar in patients with lamellar ichthyosis (LI) and healthy controls, whereas oral treatment of LI with liarozole, results in an atypical expression pattern, Acta Derm-Venereol 89 (2009) 12-20.
30. van Pelt J.P., de Jong E.M., de Bakker E.S., and van de Kerkhof P.C. Effects of systemic treatment with liarozole on cutaneous inflammation, epidermal proliferation and differentiation in extensive plaque psoriasis. Skin Pharmacol. Appl. Skin Physiol. 11 (1998) 70-79
31. E. Pavez Loriè, M. Cools, M. Borgers, L. Wouters, L. Vandeplassche, E. Hagforsen, H. Törmä, A. Vahlquist, Topical treatment with CYP26 inhibitor talarozole (R115866) dose-dependently alters the expression of retinoid-regulated genes in normal human epidermis, Br. J. Dermatol. 160 (2009) 26-36.
32. Verfaille C.J., Coel M., Boersma I.H., Mertens J., Borgers M., and Roseeuw D. Oral R115866 in the treatment of moderate to severe facial acne vulgaris: an exploratory study. Br. J. Dermatol. 157 (2007) 122-126
33. Verfaille C.J., Thissen C.A., Bovenschen H.J., Mertens J., Steijlen P.M., and van de Kerkhof P.C. Oral R115866 in the treatment of moderate to severe plaque-type psoriasis. J. Eur. Acad. Dermatol. Venereol. 21 (2007) 1038-1046
34. Langton S., and Gudas L.J. CYP26A1 knockout embryonic stem cells exhibit reduced differentiation and growth arrest in response to retinoic acid. Dev. Biol. 315 (2008) 331-354
35. Sonneveld E., van den Brink C.E., van der Leede B.M., Schulkes R.K., Petkovich M., van der Burg B., and van der Saag P.T. Human retinoic acid (RA) 4-hydroxylase (CYP26) is highly specific for all-trans-RA and can be induced through RA receptors in human breast and colon carcinoma cells. Cell Growth Differ. 9 (1998) 629-637
36. Weston A.D., Blumberg B., and Underhill T.M. Active repression by unliganded retinoid receptors in development: less is sometimes more. J. Cell Biol. 161 (2003) 223-228
37. White R.J., Nie Q., Lander A.D., and Schilling T.F. Complex regulation of cyp26a1 creates a robust retinoic acid gradient in the zebrafish embryo. PLoS Biol. 5 (2007) e304
38. Sakai Y., Luo T., McCaffery P., Hamada H., and Drager U.C. CYP26A1 and CYP26C1 cooperate in degrading retinoic acid within the equatorial retina during later eye development. Dev. Biol. 276 (2004) 143-157
39. Uehara M., Yashiro K., Mamiya S., Nishino J., Chambon P., Dolle P., and Sakai Y. CYP26A1 and CYP26C1 cooperatively regulate anterior-posterior patterning of the developing brain and the production of migratory cranial neural crest cells in the mouse. Dev. Biol. 302 (2007) 399-411
40. Elder J., Cromie M., Griffiths C., Chambon P., and Voorhees J. Stimulus-selective induction of CRABP-II mRNA: a marker for retinoic acid action in human skin. J. Invest. Dermatol. 100 (1993) 356-359
41. Karlsson T., Virtanen M., Sirsjö A., Rollman O., Vahlquist A., and Törmä H. Topical retinoic acid alters the expression of cellular retinoic acid-binding protein-I and cellular retinoic acid-binding protein-II in non-lesional but not lesional psoriatic skin. Exp. Dermatol. 11 (2002) 143-152
42. Jurukovski V., Markova N.G., Karaman-Jurukovska N., Randolph R.K., Su J., Napoli J.L., and Simon M. Cloning and characterization of retinol dehydrogenase transcripts expressed in human epidermal keratinocytes. Mol. Genet. Metab. 67 (1999) 62-73
43. Markova N.G., Pinkas-Sarafova A., Karaman-Jurukovska N., Jurukovski V., and Simon M. Expression pattern and biochemical characteristics of a major epidermal retinol dehydrogenase. Mol. Genet. Metab. 78 (2003) 119-135
44. Gomaa M.S., Yee S.W., Milbourne C.E., Barbera M.C., Simons C., and Brancale A. Homology model of human retinoic acid metabolising enzyme cytochrome P450 26A1 (CYP26A1): active site architecture and ligand binding. J. Enzyme Inhib. Med. Chem. 21 (2006) 361-369
45. Gough W.H., VanOoteghem S., Sint T., and Kedishvili N.Y. cDNA cloning and characterization of a new human microsomal NAD+-dependent dehydrogenase that oxidizes all-trans-retinol and 3alpha-hydroxysteroids. J. Biol. Chem. 273 (1998) 19778-19785
46. Törmä H., Geijer S., Gester T., Alpholm K., Berne B., and Lindberg M. Variations in the mRNA expression of inflammatory mediators, markers of differentiation and lipid-metabolizing enzymes caused by sodium lauryl sulphate in cultured human keratinocytes. Toxicol In Vitro 20 (2006) 472-479
47. Virtanen M., Törmä H., and Vahlquist A. Keratin 4 upregulation by retinoic acid in vivo: a sensitive marker for retinoid bioactivity in human epidermis. J. Invest. Dermatol. 114 (2000) 487-493
48. Törmä H., Rollman O., and Vahlquist A. The vitamin A metabolism and expression of retinoid-binding proteins differ in HaCaT cells and normal human keratinocytes. Arch. Dermatol. Res. 291 (1999) 339-345
49. Gaub M.-P., Lutz Y., Ghyselinck N.B., Scheuer I., Pfister V., Chambon P., and Rochette-Egly C. Nuclear detection of cellular retinoic acid binding proteins I and II with new antibodies. J. Histochem. Cytochem. 46 (1998) 1103-1111